Valeritas

Valeritas is a commercial-stage medical technology company based in Bridgewater, New Jersey. The company employs 15 people and generates $50 million in annual revenue. Valeritas focuses on developing and commercializing innovative technologies to improve the lives of people with diabetes. Valeritas' flagship product is the V-Go Wearable Insulin Delivery Device, designed for patients with Type 2 diabetes who require insulin to manage their condition. V-Go is a small, discreet, and easy-to-use device that delivers insulin continuously over 24 hours at preset rates and allows for on-demand bolus dosing. V-Go aims to simplify insulin management by enabling patients to mimic the body's natural insulin delivery pattern. Unlike traditional methods requiring multiple daily injections, V-Go allows patients to manage their diabetes without disrupting their daily routines. Real-world analyses have shown V-Go consistently lowers A1C levels while requiring less insulin. Visit valeritas.com or contact Valeritas directly for further information.